LIMINATUS PHARMA INC.
Review SEC Form 13F institutional ownership, reported holding value and quarterly holder changes for LIMINATUS PHARMA INC. *W EXP 04/30/203, CUSIP 53271X116.
Review SEC Form 13F institutional ownership, reported holding value and quarterly holder changes for LIMINATUS PHARMA INC. *W EXP 04/30/203, CUSIP 53271X116.